Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
40.95
-0.06 (-0.15%)
At close: May 26, 2026, 4:00 PM EDT
42.19
+1.24 (3.04%)
After-hours: May 26, 2026, 7:48 PM EDT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $2.08 billion as of May 26, 2026. Its market cap has increased by 1,023.56% in one year.
Market Cap
2.08B
Enterprise Value
2.13B
1-Year Change
1,023.56%
Ranking
Category
Stock Price
$40.95
Market Cap Chart
Since the IPO on November 21, 2016, Nanobiotix's market cap has increased from $249.91M to $2.08B, an increase of 733.68%. That is a compound annual growth rate of 24.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 2.08B | 88.10% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 2.26B |
| Nektar Therapeutics | 2.25B |
| Zai Lab | 2.09B |
| Pharvaris | 2.07B |
| Trevi Therapeutics | 2.01B |
| Mesoblast | 1.97B |
| Aurinia Pharmaceuticals | 1.96B |
| Ascentage Pharma Group International | 1.96B |